MYC Overexpression Confers Sensitivity to TACC3 Inhibition for Triple-Negative Breast Cancer
Jacobo Jacobo, M.; Aung, J.; O'Brien, C.; Rugo, H. S.; Klefstrom, J.; Bandyopadhyay, S.; Goga, A.
Show abstract
The oncogenic transcription factor MYC is overexpressed across many cancer types, including triple-negative breast cancers (TNBCs), where it drives cell proliferation, chromosomal instability, and immune suppression. As MYC has proven difficult to target directly, identifying vulnerabilities created by MYC-driven mitotic rewiring is of significant therapeutic interest. Using a focused pharmacological screen of mitosis-related targets that are overexpressed in the context of MYC signaling, we identified several previously unrecognized dependencies on mitotic spindle proteins, including KIF18A and TACC3 in MYCHIGH cells. We focused on TACC3 and found the small molecule inhibitor BO-264 induced pronounced micronuclei formation, cell cycle arrest, transcriptional reactivation of inflammatory signaling, and heightened cytotoxicity in MYCHIGH models. TACC3 inhibition activates interferon-stimulated response element (ISRE) mediated inflammatory signaling and can activate the cGAS-STING pathway in a subset of triple-negative breast cancer contexts. Together, these findings identify TACC3 as a MYC-driven mitotic vulnerability. We highlight TACC3 inhibition as a promising strategy to impair tumor cell fitness and activate tumor-intrinsic inflammatory responses in MYC-driven cancers.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Cep55 overexpression promotes genomic instability and tumorigenesis in mice 96%
- Decorin, a novel negative modulator of E-cadherin in inflammatory breast cancer 95%
- Neutrophil Extracellular Trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting metastasis of pancreatic tumours 95%
Similar papers in this journal
- Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification 97%
- RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence 96%
- CRISPR Screens Identify Novel Regulators of cFLIP Dependency and Ligand-Independent, TRAIL-R1-Mediated Cell Death 96%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.